China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...

Commentary: To win the biotech battle, we don’t need entirely new strategies. We just need to avoid self-destructive policies ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...

Nestled in the Pegasus Park complex in Dallas, a globally recognized center for life science innovation, business and social ...

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at ...